The Rett Syndrome Global Registry
Launched by RETT SYNDROME RESEARCH TRUST · May 19, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Rett Syndrome Global Registry is a project that aims to gather important information about caring for individuals with Rett syndrome, a rare genetic disorder. This registry is entirely online, allowing caregivers from all over the world to share their experiences and insights. Caregivers can track their loved one's symptoms and care strategies over time, and they have the option to combine medical records for easier access. Researchers can use this collected information to better understand Rett syndrome and improve future treatments.
To participate in this registry, caregivers must be able to provide electronic consent, and they must be caring for someone diagnosed with Rett syndrome or who has a specific genetic mutation called MECP2. The registry is open to individuals of all ages, whether they are currently living or have passed away. This is a great opportunity for caregivers to contribute to research that could lead to better care and clinical trials for Rett syndrome in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Parent/caregiver must be willing and able to provide written informed consent electronically prior to entering data into the registry.
- • 2. Rett individuals of any age, living or deceased, must have a diagnosis of Rett syndrome and/or have a mutation in MECP2.
- Exclusion Criteria:
- • 1. Individuals who have a genetic mutation that is inconsistent with Rett syndrome or who have a different disorder.
- • 2. Individuals with MECP2 Duplication Syndrome
About Rett Syndrome Research Trust
The Rett Syndrome Research Trust (RSRT) is a leading non-profit organization dedicated to accelerating research and advancing therapeutic strategies for Rett syndrome, a neurodevelopmental disorder primarily affecting females. Founded by a community of families and advocates, RSRT focuses on funding innovative scientific studies, fostering collaboration among researchers, and promoting awareness of the condition. Through strategic partnerships and a commitment to rigorous scientific inquiry, RSRT aims to drive breakthroughs that will ultimately lead to effective treatments and improve the quality of life for individuals affected by Rett syndrome.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trumbull, Connecticut, United States
Patients applied
Trial Officials
Jana von Hehn, PhD
Principal Investigator
Rett Syndrome Research Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials